Bitget Brings Institutional-Grade Stablecoin Yield to All Users with USDGO, Offering Up to 4.3% APR Bitget Brings Institutional-Grade Stablecoin Yield to All Users with USDGO, Offering Up to 4.3% APR VICTORIA, Seychelles, May 20, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has launched USDGO, GO Uncapped, a passive earning initiative that […]
Continue ReadingThe award recognizes Meltwater’s AI-powered innovations that provide actionable intelligence for PR, Communications and Marketing teams SAN FRANCISCO, May 20, 2026 (GLOBE NEWSWIRE) — Meltwater, the global leader in actionable intelligence for PR, Communications and Marketing teams, has been awarded the PRWeek Global Award for Best PR Software or AI Platform, recognizing the company’s leadership in building solutions that turn […]
Continue ReadingThe award recognizes Meltwater’s AI-powered innovations that provide actionable intelligence for PR, Communications and Marketing teams SAN FRANCISCO, May 20, 2026 (GLOBE NEWSWIRE) — Meltwater, the global leader in actionable intelligence for PR, Communications and Marketing teams, has been awarded the PRWeek Global Award for Best PR Software or AI Platform, recognizing the company’s leadership in building solutions that turn […]
Continue ReadingALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its two aseptic suites in Valladolid, Spain. The $4 million dollar investment is in accordance with the EU’s GMP Annex 1 standards. The central feature of the […]
Continue ReadingALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its two aseptic suites in Valladolid, Spain. The $4 million dollar investment is in accordance with the EU’s GMP Annex 1 standards. The central feature of the […]
Continue ReadingSHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients with Alzheimer’s disease. The Phase 2 […]
Continue Reading